Alpharix

Alpharix is a vaccine designed to protect against influenza strains, including Influenza Virus B/Austria/1359417/2021-Like Strain and Influenza A/Vic. It is administered intramuscularly and is manufactured by GlaxoSmithKline Biologicals S.A.

Alpharix is used to prevent influenza, a contagious respiratory illness caused by the influenza virus. This vaccine targets specific strains of the virus, helping to reduce the risk of infection and severe complications. It is particularly important for individuals who are at higher risk of developing serious flu-related health issues.

After receiving the Alpharix vaccine, some individuals may experience common side effects such as soreness at the injection site, mild fever, or fatigue. These effects are typically temporary and resolve on their own within a few days. Severe reactions are rare but should be reported to a healthcare professional.

Before receiving the Alpharix vaccine, it is important to inform your healthcare provider about any allergies or medical conditions you have. Individuals with a history of severe allergic reactions to previous influenza vaccines should exercise caution. Always follow the storage and handling instructions provided to maintain the vaccine's effectiveness.

Alpharix may interact with certain medications or other vaccines. It is advisable to discuss your current medications with a healthcare professional before receiving this vaccine. Additionally, avoid taking over-the-counter pain relievers or fever reducers immediately after vaccination unless directed by a healthcare provider.